Susan Refice
Columbia University
7 Papers
14 Citations
Susan Refice is an academic researcher from Columbia University. The author has contributed to research in topics: Breast cancer & Diffuse optical imaging. The author has an hindex of 3, co-authored 7 publications.
Chat about Author
Papers
Presurgical Trial of Metformin in Overweight and Obese Patients with Newly Diagnosed Breast Cancer
Kevin Kalinsky,Katherine D. Crew,Susan Refice,Tong Xiao,Antai Wang,Sheldon Feldman,Bret Taback,Aqeel Ahmad,Serge Cremers,Hanina Hibshoosh,Matthew Maurer,Dawn L. Hershman +11 more
TL;DR: A presurgical trial to assess the tissue-related effects of metformin in overweight/obese breast cancer patients observed reductions in other relevant biomarkers, including BMI, cholesterol, and leptin.
Predicting tumor response in breast cancer patients using diffuse optical tomography
Jacqueline Gunther,Emerson A. Lim,Hyun K. Kim,Molly Lara Flexman,Susan Refice,Mindy Brown,Kevin Kalinsky,Dawn L. Hershman,Andreas H. Hielscher +8 more
- 12 May 2013
TL;DR: Preliminary results have shown that tumor response can be predicted by the second week of treatment and a diffuse optical tomography imaging system to track breast tumor progression in patients undergoing neoadjuvant chemotherapy is developed.
Combined dynamic and static optical tomography for prediction of treatment outcome in breast cancer patients
Jacqueline Gunther,Emerson A. Lim,Hyun K. Kim,Molly Lara Flexman,Lukas Zweck,Sindhiya Arora,Susan Refice,Mindy Brown,Kevin Kalinsky,Dawn L. Hershman,Andreas H. Hielscher +10 more
- 16 Jul 2015
TL;DR: Evidence that a combination of dynamic and static diffuse optical tomography can be used to predict treatment response in patients undergoing neo adjuvant chemotherapy is explored.
4
Chemotherapy Monitoring of Breast Cancer Patients with a Dual-Breast Dynamic Optical Tomography System
Jacqueline Gunther,Emerson A. Lim,Hyun K. Kim,Molly Lara Flexman,Susan Refice,Melinda Brown,Kevin Kalinsky,Dawn L. Hershman,Andreas H. Hielscher +8 more
TL;DR: Evidence that dynamic diffuse optical tomography can be used to predict treatment response in patients undergoing neoadjuvant chemotherapy is explored in a clinical pilot study.
2
Abstract P1-07-01: Safety of High-Dose Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer
Susan Refice,Dawn L. Hershman,Matthew A. Maurer,Kevin Kalinsky,Sheldon Feldman,Lois Brafman,Kd. Crew +6 more
TL;DR: A 1-year intervention of high-dose vitamin D3 20,000IU or 30,000 IU weekly is well-tolerated and able to increase serum 25-OHD above 40 ng/ml in all participants, without any episodes of hypervitaminosis D.
2